PREFACE AMENDMENTS TO THE DRUG TARIFF …

1 I03/2018 PREFACEAMENDMENTS TO THE drug TARIFFM arch accordance with regulation 89(3) of the National Health Service (Pharmaceutical and Local Pharma-ceutical Services) Regulations 2013 ( the 2013 Regulations ), the Secretary of State for Health as re-spects England and in accordance with regulation 41(4) of the National Health Service (PharmaceuticalServices) (Wales) Regulations 2013, the Welsh Ministers* as respects Wales have amended the DrugTariff and determinations made in respect of the AMENDMENTS to the drug TARIFF shall have effect from 1 August England, by virtue of regulation 91(1) of the 2013 Regulations, the NHS Commissioning Board ( theBoard ) has been appointed as a determining authority in relation to the pharmaceutical remunerationlisted Schedule 8 to the 2013 Regulations (ie types of service remuneration) and remuneration foradvanced services.

2 This means that both the Secretary of State and the Board are able to determineremuneration in these areas, although if the Secretary of State determines remuneration in theseareas, he is required to notify the Board of his intention to do so before doing so. As part of a phasedtransfer of responsibilities between the Secretary of State and the Board, the Board will be acting asthe lead determining authority in relation to the following Parts: Part IIIA Part IIIB Part VIA Part VIB Part VIC (up to Pharmaceutical Services (Advanced and Enhanced Services)(England) Directions2013)By virtue of Part VIE, the Board is also a determining authority for England for the remuneration forenhanced services and acts as the lead determining authority in that Secretary of State is the sole determining authority for all other XI, XIVD, XVIIID and XXI are rescinded in this edition of the drug the Secretary of State, NHS Commissioning Board and the Welsh Ministers make furtherdeterminations they will consult with such organisations as appear to be representative of persons towhose remuneration the determination would relate and such other persons as they considerappropriate in respect of determinations which relate to persons providing pharmaceutical services.

3 Ora category of such services in accordance with section 165 of the National Health Service Act 2006 andsection 89 of the National Health Service (Wales) Act 2006, regulations made under those sections andunder section 164 of the National Health Service Act 2006 and section 88 of the National Health Service(Wales) Act ) Effective date for all parts except those indicated in (ii)1st day of the monthii) Effective date for specific provisions in specified partsN/Aiii) Date of publication1st day of the monthTO: General Medical Practitioners, Pharmacy Contractors, Appliance Contractors ii03 note that you are now being supplied each month with the drug TARIFF which incorporates allamendments to date. All entries showing a change in price are not specifically included in this PREFACE butare indicated in the drug TARIFF by L for price reduction and K for price increase; changes to the text re-lating to code, product description, or the inclusion of a new product are indicated by a vertical line in every effort is made to ensure that each monthly publication of the drug TARIFF includes allamendments made by the Secretary of State and the Welsh Ministers to the price applicable to the rele-vant period, the need to observe printing deadlines sometimes defeats those efforts.

4 Any omitted amend-ments will be effective from the date on which they came into force, even if publication of the details isunavoidably delayed.* Functions of the National Assembly for Wales have transferred to Welsh Ministers in accordance withsection 162 of and paragraph 30 of Schedule 11 to the Government of Wales Act TO APRIL 2018 drug TO PART VIIIA EFFECTIVE FROM 1 APRIL 2018 SSpecial ContainerAdalimumab 40 solution for injection pre-filled disposable devices2 Category C HumiraAdalimumab 40 solution for injection pre-filled syringes2 Category C HumiraAdrenaline (base) 150 (1 in 1,000) solution for injection pre-filled disposable devicesS1 Category C JextAnagrelide 500microgram capsules100 Category AChloramphenicol eye drops preservative freeS10mlCategory C EykappoColistimethate 1million unit powder for solution for injection vials10 Category C ColomycinColistimethate 2million unit powder for solution for injection vials10 Category C ColomycinDegarelix 120mg powder and solvent for solution for injection vials2 Category C FirmagonDegarelix 80mg powder and solvent for solution for injection vialS1 Category C FirmagonEslicarbazepine 200mg tablets60 Category C ZebinixEslicarbazepine 800mg tablets30 Category C ZebinixIbuprofen 200mg / Phenylephrine tablets16 Category C Sudafed Sinus Pain ReliefInsulin aspart 100units/ml solution for injection cartridges5 Category C

5 NovoRapid PumpCartInsulin degludec 100units/ml solution for injection 3ml cartridges 5 Category C Tresiba PenfillInsulin degludec 100units/ml solution for injection 3ml pre-filled disposable devices 5 Category C Tresiba FlexTouchInsulin degludec 200units/ml solution for injection 3ml pre-filled disposable devices3 Category C Tresiba FlexTouchInsulin glargine 100units/ml solution for injection 10ml vialsS1 Category C LantusInsulin glargine 300units/ml solution for injection pre-filled disposable devices3 Category C Toujeo SoloStarLinagliptin / Metformin 1g tablets56 Category C JentaduetoLinagliptin / Metformin 850mg tablets56 Category C JentaduetoLorazepam 1mg/ml oral solution150mlCategory C Thame Laboratories LtdMidazolam 10mg/1ml oromucosal solution pre-filled oral syringes sugar freeS1 Category C EpistatusOxycodone 40mg / Naloxone 20mg modified-release tablets56 Category C TarginactPaliperidone 100mg/1ml suspension for injection pre-filled syringesS1 Category C XeplionPaliperidone 150 suspension for injection pre-filled syringesS1 Category C XeplionPaliperidone 50 suspension for injection pre-filled syringesS1 Category C XeplionPaliperidone 75 suspension for injection pre-filled syringesS1 Category C Xeplioniv03 FROM APRIL 2018 drug FROM PART IX EFFECTIVE FROM 1 APRIL 2018 See Pages.

6 464, 465, 474, 484, 720, CHANGES TO APRIL 2018 drug CHANGES TO PART VIIIA EFFECTIVE FROM 1 APRIL 2018 Perampanel 2mg tablets7 Category C Fycompa28 Category C FycompaPerampanel 4mg tablets28 Category C FycompaPerampanel 6mg tablets28 Category C FycompaPerampanel 8mg tablets28 Category C FycompaPerampanel 10mg tablets28 Category C FycompaPerampanel 12mg tablets28 Category C FycompaRisperidone 25mg powder and solvent for suspension for injection vialsS1 Category C Risperdal ConstaRisperidone powder and solvent for suspension for injection vialsS1 Category C Risperdal ConstaRisperidone 50mg powder and solvent for suspension for injection vialsS1 Category C Risperdal ConstaSomatropin (epr) 5 solution for injection cartridgesS1 Category C Norditropin SimpleXxSomatropin (epr) 10 solution for injection cartridgesS1 Category C Norditropin SimpleXxSomatropin (epr) 15 solution for injection cartridgesS1 Category C Norditropin SimpleXxSomatropin (rmc) 12 solution for injection cartridgesS1 Category C SaizenSomatropin (rmc) 20 solution for injection cartridgesS1 Category C SaizenSomatropin (rmc) 6 solution for injection cartridgesS1 Category C SaizenTacrolimus 3mg modified-release capsulesS50 Category C AdvagrafTacrolimus 5mg modified-release capsulesS50 Category C AdvagrafTyphoid polysaccharide 25 vaccine solution for injection pre-filled syringes1 Category C Ty phim Vi10 Category C Ty phim ViCarbocisteine 250mg/5ml oral solution300mlCategory C Mucodyne Syrup will be.

7 Carbocisteine 250mg/5ml oral solution300mlCategory ACo-amoxiclav 875mg/125mg tablets14 Category C Creo Pharma Ltd will be:Co-amoxiclav 875mg/125mg tablets14 Category C Brown & Burk UK Ltdv03 TO MARCH 2018 drug OF HEALTH - REBRANDC ontractors should note references to the Department of Health (DH) have been amended to Departmentof Health and Social Care (DHSC). TO MARCH 2018 drug II - REQUIREMENTS ENABLING PAYMENTS TO BE MADE FOR THE SUPPLY OF DRUGS,APPLIANCES AND CHEMICAL REAGENTSPAGE 22 - DRUGS FOR WHICH DISCOUNT IS NOT DEDUCTEDI ndividual ItemsTerbutaline solution for injection VIIIA - BASIC PRICES OF DRUGSPAGE 172 PAGE 184 PAGE 191 PAGE 200 SSpecial Container*This pack only (others already available)Fluoxetine 10mg tablets304400 ALanreotide 60 solution for injection pre-filled syringesS155100 CSomatuline AutogelLanreotide 90 solution for injection pre-filled syringesS173600 CSomatuline AutogelMesalazine 250mg gastro-resistant tablets1001619 CSalofalkMesalazine 500mg gastro-resistant modified-release granules sachets sugar free1002874 CSalofalkMesalazine 500mg gastro-resistant tablets1003238 CSalofalkNystatin 100,000units/g / Chlorhexidine acetate 1% / Hydrocortisone 1% ointmentS30g529 ANystatin 100.

8 000units/g / Chlorhexidine hydrochloride 1% / Hydrocortisone creamS30g529 Avi03/2018 PREFACEPAGE 211 PAGE 219 PAGE 222 IXA - APPLIANCESPAGE 245 - ANAL IRRIGATION SYSTEMPAGE 316 - DRESSINGS Wound Management Dressings Protease Modulating Matrix - SterilePAGE 326 Soft Silicone Wound Contact Dressing - SterileRanitidine 150mg/5ml oral solution sugar free150ml550 CCreo Pharma LtdSoya oil bath oilS500ml538 CBalneum1000(2xS500)ml1039 CBalneum* Tenoxicam 20mg tablets301342 CMobiflexTerbutaline solution for injection ampoules102009 CBricanylTerbutaline 500micrograms/1ml solution for injection ampoules5648 CBricanyloProducts marked with this symbol must be dispensed with a supply of wipes and disposal bagsoNavina Classic System - small690077462(System includes 1 Navina Classic control unit, 1 water container, 1 tube set, 2small rectal catheters, 1 accessory set, 1 Navina case)oNavina Smart System - small6901029850(System includes 1 control unit, 2 small rectal catheters, 1 water container, 1 tubeset, 1 accessory set, 1 Navina case)oNavina Consumable Set - small6900412927(Contains 15 small rectal catheters, 1 water container)

9 Pack of 10oNavina Rectal Catheter Set - small689438144(Contains 10 small rectal catheters)Cutimed Sorbion SorbactSquare10cm x 10cm58020cm x 20cm1568 Rectangular10cm x 20cm90620cm x 30cm2352 Adaptic DigitFingerSmall 2cm diameter146 Medium diameter158 Large diameter176 Extra Large 3cm diameter176vii03/2018 PREFACEPAGE 338 Transparent Absorbent Acrylic Dressing with Adhesive BorderPAGE 347 - EMOLLIENT AND BARRIER PREPARATIONSP reparations containing UreaPAGE 356 - HYPODERMIC EQUIPMENTN eedles for Pre-filled and Reusable Pen Injectorspack of 100 PAGE 367 - LOW FRICTION IXB - INCONTINENCE APPLIANCESPAGE 507 - NIGHT DRAINAGE BAGSG reat Bear Healthcare IXC - STOMA APPLIANCESPAGE 689 - SKIN FILLERS AND IXR - CHEMICAL REAGENTSPAGE 771 - DETECTION STRIPS, BLOOD FOR GLUCOSEB iosensor Strips - to be read only with the appropriate meterLeukomed Control5cm x 7cm (wound contact pad 2cm x 4cm)1147cm x 10cm (wound contact pad 4cm x 7cm)1708cm x 15cm (wound contact pad x )20710cm x 24cm (wound contact pad 6cm x 20cm)48010cm x 35cm (wound contact pad 6cm x 31cm)

10 577 Ultraveen Itch Relief Cream125ml349500ml1105 Dropsafe Safety Pen Needles6mm/31 gauge23008mm/31 gauge2300 GlucoRx CarePoint10mm/29 gauge395 PrevalonHeel ProtectorICalf Circ 25-46cm3860 IIICalf Circ 25-46cm4400 PetiteCalf Circ 13-25cm4400 USingle use onlyUGB5 3 litre night bag with 120cm tube, single use T-tap andsafety clip10330Y10590 Medline Industries LtdRemedy Barrier Moisturising CreamMSCE92534PK2ml34 MSCE09253130ml309 MSCE309534118ml609 True Metrix50990viii03 XV - BORDERLINE SUBSTANCESPAGE 810 - LIST AGlytactin Bettermilk Lite 20 PhenylketonuriaPAGE 811 - LIST AGlytactin Build 10 PhenylketonuriaGlytactin Complete 15 (Fruit Frenzy And Peanut Butter flavours)PhenylketonuriaGlytactin R